GlycoMimetics (FRA:GKO) Institutional Ownership : 11.04% (As of May. 16, 2024)

View and export this data going back to 2014. Start your Free Trial

What is GlycoMimetics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, GlycoMimetics's institutional ownership is 11.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, GlycoMimetics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, GlycoMimetics's Float Percentage Of Total Shares Outstanding is 69.60%.

GlycoMimetics Institutional Ownership Historical Data

The historical data trend for GlycoMimetics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoMimetics Institutional Ownership Chart

GlycoMimetics Historical Data

The historical data trend for GlycoMimetics can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	12.51	12.75	12.75	12.64	10.20	10.19	10.20	10.97	10.97	11.04

GlycoMimetics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

GlycoMimetics (FRA:GKO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoMimetics Inc (FRA:GKO) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

GLYC:USA

Address

9708 Medical Center Drive, Rockville, MD, USA, 20850

Website

https://www.glycomimetics.com

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.